These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 29910804)

  • 41. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.
    Yi T; Zhao D; Lin CL; Zhang C; Chen Y; Todorov I; LeBon T; Kandeel F; Forman S; Zeng D
    Blood; 2008 Sep; 112(5):2101-10. PubMed ID: 18596226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of suppressing retinoic acid-related orphan receptor gamma t (ROR)γt in ameliorating central nervous system autoimmunity.
    Yang Y; Winger RC; Lee PW; Nuro-Gyina PK; Minc A; Larson M; Liu Y; Pei W; Rieser E; Racke MK; Lovett-Racke AE
    Clin Exp Immunol; 2015 Jan; 179(1):108-18. PubMed ID: 25142403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-IL-12/23 p40 antibody attenuates experimental chronic graft-versus-host disease via suppression of IFN-γ/IL-17-producing cells.
    Okamoto S; Fujiwara H; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanaka T; Yoshimura A; Tanimoto M; Maeda Y
    J Immunol; 2015 Feb; 194(3):1357-63. PubMed ID: 25527789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORγt.
    Fulton LM; Carlson MJ; Coghill JM; Ott LE; West ML; Panoskaltsis-Mortari A; Littman DR; Blazar BR; Serody JS
    J Immunol; 2012 Aug; 189(4):1765-72. PubMed ID: 22778391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor progression locus 2 differentially regulates IFNγ and IL-17 production by effector CD4+ T cells in a T cell transfer model of colitis.
    Acuff NV; Li X; Kirkland R; Nagy T; Watford WT
    PLoS One; 2015; 10(3):e0119885. PubMed ID: 25781948
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological Evaluation of TAK-828F, a Novel Orally Available RORγt Inverse Agonist, on Murine Colitis Model.
    Igaki K; Nakamura Y; Komoike Y; Uga K; Shibata A; Ishimura Y; Yamasaki M; Tsukimi Y; Tsuchimori N
    Inflammation; 2019 Feb; 42(1):91-102. PubMed ID: 30121880
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease.
    Yang J; Ramadan A; Reichenbach DK; Loschi M; Zhang J; Griesenauer B; Liu H; Hippen KL; Blazar BR; Paczesny S
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30694220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism.
    Eken A; Singh AK; Treuting PM; Oukka M
    Mucosal Immunol; 2014 Jan; 7(1):143-54. PubMed ID: 23715173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Zhao K; Zhao D; Huang D; Song X; Chen C; Pan B; Wu Q; Cao J; Yao Y; Zeng L; Xu K
    Immunobiology; 2013 Dec; 218(12):1505-13. PubMed ID: 23816304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An RORγt Oral Inhibitor Modulates IL-17 Responses in Peripheral Blood and Intestinal Mucosa of Crohn's Disease Patients.
    Bassolas-Molina H; Raymond E; Labadia M; Wahle J; Ferrer-Picón E; Panzenbeck M; Zheng J; Harcken C; Hughes R; Turner M; Smith D; Calderón-Gómez E; Esteller M; Carrasco A; Esteve M; Dotti I; Corraliza AM; Masamunt MC; Arajol C; Guardiola J; Ricart E; Nabozny G; Salas A
    Front Immunol; 2018; 9():2307. PubMed ID: 30405600
    [No Abstract]   [Full Text] [Related]  

  • 52. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Helper T-cell differentiation in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Fu J; Heinrichs J; Yu XZ
    Arch Immunol Ther Exp (Warsz); 2014 Aug; 62(4):277-301. PubMed ID: 24699629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Max interacting protein 1 induces IL-17-producing T helper/regulatory T imbalance in osteoarthritis by upregulating tectonic family member 2.
    Li X; Xiao S; Li F; Fang K; Wen J; Gong H
    Tissue Cell; 2022 Oct; 78():101906. PubMed ID: 36049372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Runx1 and RORγt Cooperate to Upregulate IL-22 Expression in Th Cells through Its Distal Enhancer.
    Sekimata M; Yoshida D; Araki A; Asao H; Iseki K; Murakami-Sekimata A
    J Immunol; 2019 Jun; 202(11):3198-3210. PubMed ID: 31028121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of graft-versus-host disease by interleukin-2 treatment is associated with altered cytokine production by expanded graft-versus-host-reactive CD4+ helper cells.
    Wang MG; Szebeni J; Pearson DA; Szot GL; Sykes M
    Transplantation; 1995 Sep; 60(5):481-90. PubMed ID: 7676498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Th17/Treg imbalance in patients with acute coronary syndrome.
    Cheng X; Yu X; Ding YJ; Fu QQ; Xie JJ; Tang TT; Yao R; Chen Y; Liao YH
    Clin Immunol; 2008 Apr; 127(1):89-97. PubMed ID: 18294918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diverting T helper cell trafficking through increased plasticity attenuates autoimmune encephalomyelitis.
    Califano D; Sweeney KJ; Le H; VanValkenburgh J; Yager E; O'Connor W; Kennedy JS; Jones DM; Avram D
    J Clin Invest; 2014 Jan; 124(1):174-87. PubMed ID: 24316973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting cellular fatty acid synthesis limits T helper and innate lymphoid cell function during intestinal inflammation and infection.
    Mamareli P; Kruse F; Lu CW; Guderian M; Floess S; Rox K; Allan DSJ; Carlyle JR; Brönstrup M; Müller R; Berod L; Sparwasser T; Lochner M
    Mucosal Immunol; 2021 Jan; 14(1):164-176. PubMed ID: 32355319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa.
    Watanabe M; Ueno Y; Yajima T; Okamoto S; Hayashi T; Yamazaki M; Iwao Y; Ishii H; Habu S; Uehira M; Nishimoto H; Ishikawa H; Hata J; Hibi T
    J Exp Med; 1998 Feb; 187(3):389-402. PubMed ID: 9449719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.